JPWO2024181525A1 - - Google Patents
Info
- Publication number
- JPWO2024181525A1 JPWO2024181525A1 JP2025503986A JP2025503986A JPWO2024181525A1 JP WO2024181525 A1 JPWO2024181525 A1 JP WO2024181525A1 JP 2025503986 A JP2025503986 A JP 2025503986A JP 2025503986 A JP2025503986 A JP 2025503986A JP WO2024181525 A1 JPWO2024181525 A1 JP WO2024181525A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18733—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18741—Use of virus, viral particle or viral elements as a vector
- C12N2760/18743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363449055P | 2023-03-01 | 2023-03-01 | |
| PCT/JP2024/007475 WO2024181525A1 (ja) | 2023-03-01 | 2024-02-29 | 抗がん剤、がん治療用医薬組成物、キット、及び活性化剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2024181525A1 true JPWO2024181525A1 (cg-RX-API-DMAC7.html) | 2024-09-06 |
Family
ID=92589933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025503986A Pending JPWO2024181525A1 (cg-RX-API-DMAC7.html) | 2023-03-01 | 2024-02-29 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4674421A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2024181525A1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN120916775A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024181525A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1213004A (zh) * | 1997-09-29 | 1999-04-07 | 成都拜奥生物技术研究所 | 重组白细胞介素-2腺病毒载体及产生方法 |
| JP5801202B2 (ja) | 2009-09-29 | 2015-10-28 | 学校法人慶應義塾 | 抗腫瘍剤およびそのスクリーニング方法 |
| JP5807917B2 (ja) | 2011-02-08 | 2015-11-10 | 国立大学法人三重大学 | 遺伝子導入用ウイルスベクターの製造方法 |
| JP6358706B2 (ja) | 2012-12-26 | 2018-07-18 | バイオコモ株式会社 | ヒトパラインフルエンザ2型ウイルスベクターを利用したワクチン |
| AU2017272721B2 (en) * | 2016-05-30 | 2023-03-30 | Astellas Pharma Inc. | Novel genetically engineered vaccinia viruses |
| KR20230100748A (ko) | 2016-07-28 | 2023-07-05 | 노파르티스 아게 | 키메라 항원 수용체 및 pd-1 억제제의 조합 요법 |
| CA3075886A1 (en) * | 2017-10-10 | 2019-04-18 | Yamaguchi University | Enhancer for t-cells or b-cells having memory function, malignant tumor recurrence inhibitor, and inducer for inducing memory function in t-cells or b-cells |
| US20210379129A1 (en) | 2018-10-09 | 2021-12-09 | Biocomo Incorporation | Anticancer agent, pharmaceutical composition for cancer treatment, and kit |
-
2024
- 2024-02-29 JP JP2025503986A patent/JPWO2024181525A1/ja active Pending
- 2024-02-29 CN CN202480015575.2A patent/CN120916775A/zh active Pending
- 2024-02-29 WO PCT/JP2024/007475 patent/WO2024181525A1/ja not_active Ceased
- 2024-02-29 EP EP24764002.2A patent/EP4674421A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024181525A1 (ja) | 2024-09-06 |
| EP4674421A1 (en) | 2026-01-07 |
| CN120916775A (zh) | 2025-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR102023005164A2 (cg-RX-API-DMAC7.html) | ||
| BR102022025291A2 (cg-RX-API-DMAC7.html) | ||
| BR112025024041B1 (pt) | Elemento de despejamento para uma embalagem compósita e embalagem compósita com um elemento de despejamento | |
| BR112025020304B1 (pt) | Liga de solda, esfera de solda, pré-forma de solda, junta de solda e circuito | |
| BR112025008516B1 (pt) | Método tudo em um de recuperação de níquel para recuperar níquel a partir de matérias-primas contendo níquel | |
| BR112025016688B1 (pt) | Compostos e composições farmacêuticas | |
| BR112025012384B1 (pt) | Método, aparelho e sistema para produzir uma pluralidade de mudas enraizadas a partir de uma pluralidade de mudas não enraizadas, e, método para plantar mudas enraizadas | |
| BR112025011041B1 (pt) | Dispositivo para inspeção de um elemento roscado e método de inspeção correspondente | |
| BR112024022558B1 (pt) | Polipeptídeo, polinucleotídeo, ácido nucleico, vetor, célula hospedeira, método para produzir o polipeptídeo, composição, e, método in vitro para aumentar adesão celular | |
| BR112025005915B1 (pt) | Gerador, dispositivo e método de ablação de campo pulsado | |
| BR112025005363B1 (pt) | Equipamento de usuário, entidade de rede e métodos relacionados | |
| BR102023016405B1 (pt) | Estrutura de viga de pá, pá de energia eólica e equipamento de energia eólica | |
| BR112024026850B1 (pt) | Triturador de mandíbula e método de serviço ou de manutenção de um triturador de mandíbula | |
| BR112024025233B1 (pt) | Método para alterar o estado de elevação vertical para um veículo transportador, controle e veículo | |
| BR102023009702B1 (pt) | Dispositivo para alisamento e aplicação de substância de tratamento | |
| BR112024027500B1 (pt) | Polipeptídeo, ácido nucleico, vetor, célula hospedeira, método para produzir o polipeptídeo, composição, uso do polipeptídeo, e, método para promover a proliferação de uma célula in vitro | |
| BR102023002997B1 (pt) | Um aparelho para detecção de vazamento de um gás e um método e um sistema do mesmo | |
| BR112024018530B1 (pt) | Método para determinar nível de escória do alto-forno, método para operar alto-forno e unidade de controle | |
| BR112024027130B1 (pt) | Sistema e método para um conjunto de cuff (balão) de tubo endotraqueal | |
| BR102022026432B1 (pt) | Dispositivo de transferência de esforços transversais em juntas de dilatação | |
| BR102022024748B1 (pt) | Equipamento extrator de esporos da superfície de grãos de cereal para aplicação em laboratório e seu processo operacional | |
| BR122025008969A2 (pt) | Método para decodificar um vídeo, sistema e mídia legível por computador | |
| BR122025008973A2 (pt) | Sistema, método para decodificar um vídeo e mídia legível por computador | |
| BR122025008972A2 (pt) | Sistema, método para decodificar um vídeo e mídia legível por computador | |
| BR122025008970A2 (pt) | Método para decodificar um vídeo, sistema e mídia legível por computador |